Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-[4-(Bromomethyl)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol | HCID 23527396 | — |
| Reactant | tert-Butyl (3R)-3-(hydroxymethyl)piperazine-1-carboxylate | HCID 24820286 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 86638555 | HCID 86638555 | 49.5% |
Reaction Steps
To a stirred solution of (R)-tert-butyl 3-(hydroxymethyl)piperazine-1-carboxylate (231 mg, 1.07 mmol), 2-(4-(bromomethyl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol (400 mg, 1.19 mmol) and sodium iodide (18 mg, 0.12 mmol) in acetonitrile (10 mL) was added potassium carbonate (655 mg, 4.75 mmol). The reaction mixture was stirred at room temperature for 3 days, before being diluted with dichloromethane (10 mL), filtered through cotton wool and concentrated under reduced pressure. The residue was purified by flash column chromatography (eluting with dichloromethane to 10% methanol in dichloromethane) to afford the intermediate (R)-tert-butyl 4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzyl)-3-(hydroxymethyl)piperazine-1-carboxylate (250 mg, 0.53 mmol). To a stirred solution of (R)-tert-butyl 4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzyl)-3-(hydroxymethyl)piperazine-1-carboxylate (220 mg, 0.466 mmol) in dichloromethane (3 mL), was added trifluoroacetic acid (3 mL, 38.3 mmol). The reaction mixture was stirred at room temperature for 5 hours before being purified directly by SCX chromatography, eluting with 2N ammonia in methanol solution to afford the title compound (165 mg). MS (ESI) m/z 373.3 [M+H]+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08357679B2 |
|---|
| Source dataset | uspto-grants-2013_01 |
|---|
| ORD ID | ord-bf3e6ee830ad4e87a03ff9ca3c53c181 |
|---|
| Source note | uspto-grants-2013_01 |
|---|